- Home
- WDH vs ARVN Comparison
WDH vs ARVN Comparison
Compare WDH & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- ARVN
- Stock Information
- Founded
- WDH 2016
- ARVN 2015
- Country
- WDH China
- ARVN United States
- Employees
- WDH N/A
- ARVN N/A
- Industry
- WDH Specialty Insurers
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- WDH Finance
- ARVN Health Care
- Exchange
- WDH Nasdaq
- ARVN Nasdaq
- Market Cap
- WDH 694.4M
- ARVN 676.2M
- IPO Year
- WDH 2021
- ARVN 2018
- Fundamental
- Price
- WDH $1.67
- ARVN $9.54
- Analyst Decision
- WDH
- ARVN Buy
- Analyst Count
- WDH 0
- ARVN 23
- Target Price
- WDH N/A
- ARVN $17.80
- AVG Volume (30 Days)
- WDH 287.0K
- ARVN 2.5M
- Earning Date
- WDH 12-10-2025
- ARVN 11-05-2025
- Dividend Yield
- WDH 3.64%
- ARVN N/A
- EPS Growth
- WDH 71.77
- ARVN N/A
- EPS
- WDH 0.17
- ARVN N/A
- Revenue
- WDH $416,345,794.00
- ARVN $372,800,000.00
- Revenue This Year
- WDH N/A
- ARVN N/A
- Revenue Next Year
- WDH $7.72
- ARVN N/A
- P/E Ratio
- WDH $10.32
- ARVN N/A
- Revenue Growth
- WDH 9.39
- ARVN 299.57
- 52 Week Low
- WDH $1.05
- ARVN $5.90
- 52 Week High
- WDH $2.18
- ARVN $28.83
- Technical
- Relative Strength Index (RSI)
- WDH 33.99
- ARVN 53.98
- Support Level
- WDH $1.69
- ARVN $9.01
- Resistance Level
- WDH $1.78
- ARVN $10.18
- Average True Range (ATR)
- WDH 0.05
- ARVN 0.43
- MACD
- WDH -0.01
- ARVN -0.05
- Stochastic Oscillator
- WDH 2.50
- ARVN 41.41
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.